Gut microbiota has been shown to be involved in the development of metabolic syndrome and low-grade inflammation associated with obesity via different mechanisms including lipopolysaccarides-Toll-like receptors/CD14 (LPS-TLRs/CD14) complex mostly in animal models [14]. Here, CD14 is linked to metabolic syndrome.